BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10622450)

  • 1. Fluorescence automatic cell sorter and immunohistochemical investigation of CD68-positive cells in meningioma.
    Asai J; Suzuki R; Fujimoto T; Suzuki T; Nakagawa N; Nagashima G; Miyo T; Hokaku H; Takei A
    Clin Neurol Neurosurg; 1999 Dec; 101(4):229-34. PubMed ID: 10622450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical study of mononuclear cells in meningiomas.
    Bø L; Mørk SJ; Nyland H
    Neuropathol Appl Neurobiol; 1992 Dec; 18(6):548-58. PubMed ID: 1488087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor infiltrating immune cells in gliomas and meningiomas.
    Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
    Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune cell infiltration of intrinsic and metastatic intracranial tumours.
    Strik HM; Stoll M; Meyermann R
    Anticancer Res; 2004; 24(1):37-42. PubMed ID: 15015573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microglial/macrophagic response at the tumour-brain border of invasive meningiomas.
    Grund S; Schittenhelm J; Roser F; Tatagiba M; Mawrin C; Kim YJ; Bornemann A
    Neuropathol Appl Neurobiol; 2009 Feb; 35(1):82-8. PubMed ID: 19187060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
    Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation and clinical significance of LC3, CD68+ microglia, CD4+ T lymphocytes, and CD8+ T lymphocytes in gliomas.
    Zhang W; Wu S; Guo K; Hu Z; Peng J; Li J
    Clin Neurol Neurosurg; 2018 May; 168():167-174. PubMed ID: 29567578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between tumor microenvironment and clinicopathological parameters in meningioma.
    Ding Y; Qiu L; Xu Q; Song L; Yang S; Yang T
    Int J Clin Exp Pathol; 2014; 7(10):6973-9. PubMed ID: 25400783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations.
    Kataki A; Skandami V; Memos N; Nikolopoulou M; Oikonomou V; Androulis A; Konstadoulakis MM; Zografos CG
    J Neurosurg Sci; 2014 Mar; 58(1):9-15. PubMed ID: 24614787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD68 and CR3/43 immunohistochemical expression in secretory meningiomas.
    Caffo M; Caruso G; Germanò A; Galatioto S; Meli F; Tomasello F
    Neurosurgery; 2005 Sep; 57(3):551-7; discussion 551-7. PubMed ID: 16145535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study of neuroepithelial tumors in Rochester, Minnesota, 1950-1977.
    Codd MB; Kurland LT; O'Fallon WM; Beard CM; Cascino TL
    Neuroepidemiology; 1990; 9(1):17-26. PubMed ID: 2330067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating immune complexes in patients with intracranial neoplasms].
    Sztaba-Kania M; Piskorzyńska M; Borowska-Lehman J; Kopczyński S
    Nowotwory; 1982; 32(4):235-8. PubMed ID: 6310528
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammatory infiltrates and natural killer cell presence in human brain tumors.
    Stevens A; Klöter I; Roggendorf W
    Cancer; 1988 Feb; 61(4):738-43. PubMed ID: 3338036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of CD68 positive monocytes/macrophage(CD68+ Mo/M phi) in urine and infiltrated tissue of various kidney diseases in children].
    Saitoh A; Ikoma M; Kamiyama C; Doi K; Koitabashi Y
    Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):798-805. PubMed ID: 12607969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic change of human cultured meningioma cells.
    Pallini R; Casalbore P; Mercanti D; Maggiano N; Larocca LM
    J Neurooncol; 2000 Aug; 49(1):9-17. PubMed ID: 11131990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Interleukin-10 Receptors and the CD45-Immunophenotype of Central Nervous System Tumors: A Preliminary Study.
    Zadka L; Kram P; Koscinski J; Jankowski R; Kaczmarek M; Piatek K; Kulus M; Gomułkiewicz A; Piotrowska A; Dziegiel P
    Anticancer Res; 2017 Oct; 37(10):5777-5783. PubMed ID: 28982901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical study of the cellular immune response in meningiomas.
    Rossi ML; Cruz Sanchez F; Hughes JT; Esiri MM; Coakham HB
    J Clin Pathol; 1988 Mar; 41(3):314-9. PubMed ID: 3258871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.
    Kunisch E; Fuhrmann R; Roth A; Winter R; Lungershausen W; Kinne RW
    Ann Rheum Dis; 2004 Jul; 63(7):774-84. PubMed ID: 15194571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating immune complexes associated with brain tumors. Correlation with histological differentiation and length of clinical history.
    Lauro GM; Grossi M; Di Lorenzo N
    Eur Neurol; 1983; 22(5):307-13. PubMed ID: 6628459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical study on HLA-DR expression in human meningiomas.
    Ohara N; Hayashi K; Miyake K; Jeon HJ; Takahashi K; Akagi T
    Acta Neuropathol; 1992; 84(1):110-2. PubMed ID: 1380199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.